Effect of observer experience in the differentiation between benign and malignant liver tumors after ultrasound contrast agent injection

Journal of Ultrasound in Medicine

Volumn 29, Issue 1, 2010, Pages 25-36

  Quaia, Emilio ^a   Alaimo, Valerio ^b   Baratella, Elisa ^a   Pizzolato, Riccardo ^a   Cester, Giacomo ^a   Medeot, Alessandro ^a   Cova, Maria Assunta ^a  

^a UNIVERSITY OF TRIESTE   (Italy)

^b UNIVERSITY OF PALERMO   (Italy)

Author keywords

Contrast enhanced ultrasound imaging; Liver; Microbubbles; Tumor

Indexed keywords

LIVER; SULFUR HEXAFLUORIDE; TUMORS; ULTRASONIC IMAGING;

BENIGN LESION; CONTRAST ENHANCED ULTRASOUND; DIAGNOSTIC PERFORMANCE; HEPATOCELLULAR; MICROBUBBLE INJECTION; MICROBUBBLES; OVERALL ACCURACIES; ULTRASOUND CONTRAST AGENT;

DIAGNOSIS;

CONTRAST AGENT BR1; CONTRAST MEDIUM; DIAGNOSTIC AGENT; PHOSPHOLIPID; SULFUR HEXAFLUORIDE;

ARTICLE; ECHOGRAPHY; FEMALE; HUMAN; INCIDENCE; INTRAVENOUS DRUG ADMINISTRATION; ITALY; LIVER TUMOR; MALE; MIDDLE AGED; OBSERVER VARIATION; PHYSICIAN; PROFESSIONAL COMPETENCE; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; STATISTICS;

CONTRAST MEDIA; FEMALE; HUMANS; INCIDENCE; INJECTIONS, INTRAVENOUS; ITALY; LIVER NEOPLASMS; MALE; MIDDLE AGED; OBSERVER VARIATION; PHOSPHOLIPIDS; PHYSICIANS; PROFESSIONAL COMPETENCE; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SULFUR HEXAFLUORIDE; ULTRASONOGRAPHY;

EID: 75149152603     PISSN: 02784297     EISSN: None     Source Type: Journal    
DOI: 10.7863/jum.2010.29.1.25     Document Type: Article

References (29)

1. Nino Murcia M, Ralls PW, Jeffrey RB Jr, Johnson M. Color flow Doppler characterization of focal hepatic lesions. AJR Am J Roentgenol 1992; 159:1195-1197.
2. Harvey CJ, Albrecht T. Ultrasound of focal liver lesions. Eur Radiol 2001; 11:1578-1593.
3. Schneider M, Arditi M, Barrau MB, et al. BR1: a new ultrasonographic contrast agent based on sulfur hexafluoridefilled microbubbles. Invest Radiol 1995; 30:451-457.
4. Morel DR, Schwieger I, Hohn L, et al. Human pharmacokinetics and safety evaluation of SonoVue, a new contrast agent for ultrasound imaging. Invest Radiol 2000; 35:80-85.
5. Quaia E. Microbubble ultrasound contrast agents: an update. Eur Radiol 2007; 17:1995-2008.
6. Tanaka S, Ioka T, Oshikawa O, Hamada Y, Yoshioka F. Dynamic sonography of hepatic tumors. AJR Am J Roentgenol 2001; 177:799-805.
7. Dill-Macky M, Burns P, Khalili K, Wilson S. Focal hepatic masses: enhancement patterns with SH U 508A and pulse inversion US. Radiology 2002; 222:95-102.
8. Isozaki T, Numata K, Kiba T, et al. Differential diagnosis of hepatic tumors by using contrast enhancement patterns at US. Radiology 2003; 229:798-805.
9. Bryant T, Blomley MJK, Albrecht T, et al. Improved characterization of liver lesions with liver-phase uptake of liverspecific microbubbles: prospective multicenter trials. Radiology 2004; 232:799-809.
10. Wen YL, Kudo M, Zheng RQ, et al. Characterization of hepatic tumors: value of contrast-enhanced coded phaseinversion harmonic angio. AJR Am J Roentgenol 2004; 182:1019-1026.
11. Quaia E, Calliada F, Bertolotto M, et al. Characterization of focal liver lesions by contrast-specific US modes and a sulfur hexafluoride-filled microbubble contrast agent: diagnostic performance and confidence. Radiology 2004; 232:420-430.
12. Burns PN, Wilson SR. Focal liver masses: enhancement patterns on contrast-enhanced images - concordance of US scans with CT scans and MR images. Radiology 2007; 242:162-174.
13. Albrecht T, Blomley M, Bolondi L, et al; EFSUMB Study Group. Guidelines for the use of contrast agents in ultrasound. Ultraschall Med 2004; 25:249-256.
14. Claudon M, Cosgrove D, Albrecht T, et al. Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS): update 2008. Ultraschall Med 2008; 29:28-44.
15. Xu HX, Liu GJ, Lu MD, et al. Characterization of focal liver lesions using contrast-enhanced sonography with a low mechanical index mode and a sulfur hexafluoride-filled microbubble contrast agent. J Clin Ultrasound 2006; 34:261-272.
16. Quaia E, Bertolotto M, Dalla Palma L. Characterization of liver hemangiomas with pulse inversion harmonic imaging. Eur Radiol 2002; 12:537-544.
17. Kim TK, Jang HJ, Burns PN, et al. Focal nodular hyperplasia and hepatic adenoma: differentiation with low-mechanicalindex contrast-enhanced sonography. AJR Am J Roentgenol 2008; 190:58-66.
18. Nicolau C, Vilana R, Catalá V, et al. Importance of evaluating all vascular phases on contrast-enhanced sonography in the differentiation of benign from malignant focal liver lesions. AJR Am J Roentgenol 2006; 186:158-167.
19. Bismuth H. Surgical anatomy and anatomical surgery of the liver. World J Surg 1982; 6:3-8.
20. Coinaud C. Le Foie: Études Anatomiques et Chirurgicales, Paris, France: Masson; 1957.
21. Kundel HL, Polansky M. Measurement of observer agreement. Radiology 2003; 228:303-308.
22. Beck JR, Shultz EK. The use of relative operating characteristic (ROC) curves in test performance evaluation. Arch Pathol Lab Med 1986; 110:13-20.
23. Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 1983; 148:839-843.
24. Dietrich CF, Martens JC, Braden B, et al. Contrast-enhanced ultrasound of histologically proven liver hemangiomas. Hepatology 2007; 45:1139-1145.
25. Jang HJ, Kim TK, Burns P, Wilson SR. Enhancement patterns of hepatocellular carcinoma at contrast-enhanced US: comparison with histologic differentiation. Radiology 2007; 244:898-906.
26. Nicolau C, Català V, Vilana R, et al. Evaluation of hepatocellular carcinoma using SonoVue, a second-generation ultrasound contrast agent: correlation with cellular differentiation. Eur Radiol 2004; 14:1092-1099.
27. Quaia E, D'Onofrio M, Cabassa P, et al. Diagnostic value of hepatocellular nodule vascularity after sulfur hexafluoridefilled microbubble injection in patients with liver cirrhosis: analysis of diagnostic performance and confidence in malignancy characterization. AJR Am J Roentgenol 2007; 189:1474-1483.
28. Piscaglia F, Bolondi L; Italian Society for Ultrasound in Medicine and Biology (SIUMB) Study Group on Ultrasound Contrast Agents. The safety of SonoVue in abdominal applications: retrospective analysis of 23,188 investigations. Ultrasound Med Biol 2006; 32:1369-1375.
29. Sultana S, Awai K, Nakayama Y, et al. Hypervascular hepatocellular carcinomas: bolus tracking with a 40-detector CT scanner to time arterial phase imaging. Radiology 2007; 243:140-147.